Abstract
In both industrialized and developing countries, the prevalence of hypertension is increasing. The classical pathophysiology of this major cardiovascular risk factor has recently been enriched by new concepts involving the inflammation and the immune system as potential players. Indeed in certain immune-mediated inflammatory diseases such as psoriatic arthritis, rheumatoid polyarthritis or lupus erythematosus, but also degenerative arthritis, periodontitis, arterial hypertension is found more frequently than in the general population, often underdiagnosed and poorly controlled, and the cardiovascular (CV) risk is more important. The aim of this article is to review the state of knowledge on this subject, and to draw out any implications for clinical practice.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
